// App-Quantinova.ai

POS1554-HPR (2022) : HEALTH PROFESSIONALS’ PERSPECTIVES ON THE USE OF JANUS KINASE INHIBITORS TO TREAT PATIENTS WITH INFLAMMATORY ARTHRITIS

Researchers

Presenter

  • S. De Souza

Principal Investigators

  • A. Bassett

  • R. Williams

  • E. Nikiphorou

Medical Centers

  • King’s College London, Centre for Rheumatic Disease, London, United Kingdom

  • King's College Hospital, Biochemistry, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • Pfizer and Eli Lilly and Company

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved